Log In
Print
BCIQ
Print
Print this Print this
 

Stelara, ustekinumab (CNTO 1275)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHuman mAb inhibiting IL-12 and IL-23
Molecular Target Interleukin-12 (IL-12) ; Interleukin-23 (IL-23)
Mechanism of ActionInterleukin-12 (IL-12) inhibitor; Interleukin-23 (IL-23) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today